CAR-T Cell Therapy: India vs USA, UK & UAE
CAR-T cell therapy for eligible relapsed/refractory blood cancers is available at select Indian centers at a fraction of US list prices. Eligibility, manufacturing timelines, and ICU readiness drive candidacy.
Packages are quoted in USD for international patients. Families from Canada and Australia typically convert the mid-range for CAD or AUD budgeting; UK patients often compare against private GBP quotes and NHS wait timelines. Western markets guide · Free second opinion
CAR-T Cell Therapy cost: India vs other countries
Typical package ranges in USD for international patients. Families from Canada and Australia often convert the mid-range for CAD/AUD planning; UK patients compare against private GBP quotes. Final quotes follow medical review.
India
Baseline
$40,000–$80,000
USA
~6.7× higher
$300,000–$500,000
UK
~5.4× higher
$250,000–$400,000
UAE
~4.6× higher
$200,000–$350,000
We’re here to help
Get a written CAR-T Cell Therapy estimate
Share reports for a free second opinion. Most Western families receive hospital options and a USD package range within 24–48 hours.